Affin Bank
Search results
23 Feb 2024 · Pharmaniaga Berhad (Pharmaniaga) today announces a strong performance in its first quarter ended 31 March 2024 (Q1 FY2024) with Profit After Zakat and Taxation (PAT) surged almost tenfold to RM26.2 million, up from RM2.8 million in the same quarter last year, signalling a robust financial recovery. 10 MAY 2024.
Established in 1994, Pharmaniaga has evolved to become one of Malaysia’s largest listed integrated pharmaceutical groups. Our participation in the sector spans across the pharmaceutical value chain from research and development to the production of generic drugs, over-the-counter medicines, logistics and distribution, sales and marketing.
10 Mei 2024 · KUALA LUMPUR: Pharmaniaga Bhd said it "stands firm with its commitment to financial recovery amidst the opinion of its independent auditor PricewaterhouseCoopers (PWC) on the group’s 2023 ...
31 Mac 2022 · Pharmaniaga, the country’s largest listed pharmaceutical company, has a five-year strategy to move to its next phase of growth, which includes pivoting to fast-growing opportunities such as the biopharmaceutical industry, while keeping its traditional businesses such as logistics and distribution (L&D) humming.
Pharmaniaga is involved in various segments of the pharmaceutical value chain, including research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales and marketing, as well as community pharmacy.
Dismissing critics who say Pharmaniaga has little chance of clearing its vaccine inventories, its CEO says stock clearance is well under way.
4 Jan 2024 · PETALING JAYA: Pharmaniaga Bhd has entered into a concession agreement (CA) with the Ministry of Health (MOH) to undertake the procurement, storage, supply and delivery of medical products to MOH ...
Get the latest Pharmaniaga Berhad (PHARMA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
20 Feb 2024 · Pharmaniaga’s financial woes are only adding to that, and the main cause is simple enough: during the pandemic, it procured and stockpiled too many COVID-19 vaccines and was then unable to sell...
Established in 1994, Pharmaniaga has evolved to become one of Malaysia’s largest listed integrated pharmaceutical groups. Our participation in the sector spans across the pharmaceutical value chain from research and development to the production of generic drugs, over-the-counter medicines, logistics and distribution, sales and marketing.
